MeSH tree: E02.095.465
Chimeric antigen receptor (CAR)-T cell therapy, which reprograms an individual's immune cells to seek out and destroy certain cancer cells, has revolutionized treatment for blood cancers such as lymphoma. But in some patients, ...
12 hours ago
0
2
Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have remained a "blind spot" for treatment because antibodies cannot reach them. KAIST researchers have now ...
14 hours ago
0
4
In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...
Jul 22, 2026
0
7
Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune system to recognize and attack, paving the way for a new approach to improve immunotherapy. The ...
Jul 21, 2026
0
13
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical ...
Jul 14, 2026
0
5
More children younger than 5 should be able to be vaccinated in pharmacies from January 2027 under a range of measures designed to boost vaccine coverage announced in this year's federal budget.
Jul 9, 2026
0
2
Though researchers have been studying the animal deworming drug ivermectin for decades, there is no evidence that it's a safe or effective way to treat cancer in people.
Jul 8, 2026
0
9
Public health relies on data—whether it is tracking the effectiveness of a given year's flu vaccine, monitoring blood lead levels around the country or estimating the prevalence of diabetes. These data form the basis for ...
Jul 8, 2026
0
5
Women with cancer may not have the same chance of cure or quality of life as men—yet fewer than 2% of Australian cancer clinical trials report results separately for men and women. Women are also more likely to experience ...
Jul 8, 2026
0
5
Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival ...
Jul 7, 2026
0
6
